Managed Healthcare Executive provides senior-level decision makers the trends, analysis, strategies, and applications they need to innovate value in a rapidly changing healthcare landscape.
For Advertising, Custom Programs, and Web:Debby Savage
National Accounts
732-346-3053
scotth@advanstar.com
For Display, Classifieds, Product & Service Showcase, and Web:Carla Kastanis
Marketing Advisor
440-891-2711
ckastanis@advanstar.com
For Recruitment, Enews and Web:Scott Eigenbrod
Marketing Advisor
440-891-2671
seigenbrod@advanstar.com
For Lists:Tamara Phillips
Marketing Advisor
440-891-2773
tphillips@advanstar.com
For contracts, insertions orders, other instructions,publication-set copy, reproduction materials, electronic file disks andproofs:Sheila Markes
Production Manager
218-740-6509
smarkes@advanstar.com
For detailed digital ad specifications and to submit your materials, click here.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
March 20th 2025Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells genetically engineered to produce specific therapeutic proteins. It will be available in June 2025.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Increased Risk of Severe RSV Illness in Adults With Asthma or COPD
March 19th 2025Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a significant threat to adults with asthma and COPD. However, research on the virus within these groups has been limited.
Read More